• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rethinking malaria vaccines: perspectives on currently approved malaria vaccines in India's path to elimination.

作者信息

Ranjha Ritesh, Bai Priyanka, Singh Kuldeep, Mohan Mradul, Bharti Praveen K, Anvikar Anup R

机构信息

ICMR- National Institute of Malaria Research, New Delhi, India

Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India.

出版信息

BMJ Glob Health. 2024 Aug 25;9(8):e016019. doi: 10.1136/bmjgh-2024-016019.

DOI:10.1136/bmjgh-2024-016019
PMID:39182925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11404236/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d7/11404236/6df7a11bc798/bmjgh-9-8-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d7/11404236/6df7a11bc798/bmjgh-9-8-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d7/11404236/6df7a11bc798/bmjgh-9-8-g001.jpg

相似文献

1
Rethinking malaria vaccines: perspectives on currently approved malaria vaccines in India's path to elimination.重新思考疟疾疫苗：关于印度疟疾消除进程中目前已获批疟疾疫苗的观点
BMJ Glob Health. 2024 Aug 25;9(8):e016019. doi: 10.1136/bmjgh-2024-016019.
2
Malaria Elimination in India: Bridging the Gap Between Control and Elimination.印度消除疟疾：弥合控制与消除之间的差距。
Indian Pediatr. 2020 Jul 15;57(7):613-617. doi: 10.1007/s13312-020-1888-5.
3
Malaria and malnutrition together jeopardizes India's tribal community and disease elimination.疟疾和营养不良使印度的部落社区面临威胁，也影响了疾病的消除。
Pathog Glob Health. 2022 Dec;116(8):463-464. doi: 10.1080/20477724.2022.2100190. Epub 2022 Jul 12.
4
Advances in genetics and genomics: use and limitations in achieving malaria elimination goals.遗传学和基因组学的进展：在实现疟疾消除目标中的应用与局限性
Pathog Glob Health. 2015 May;109(3):123-41. doi: 10.1179/2047773215Y.0000000015.
5
MERA India: Malaria Elimination Research Alliance India.印度疟疾消除研究联盟（MERA India）：印度疟疾消除研究联盟。
J Vector Borne Dis. 2019 Jan-Mar;56(1):1-3. doi: 10.4103/0972-9062.257766.
6
Leveraging malaria vaccines and mRNA technology to tackle the global inequity in pharmaceutical research and production towards disease elimination.利用疟疾疫苗和 mRNA 技术解决全球制药研发和生产中的不平等问题，以实现疾病消除。
Malar J. 2024 May 6;23(1):136. doi: 10.1186/s12936-024-04972-5.
7
Assessment of Epidemiological Indicators for Evaluation of National Malaria Elimination Programme: A Retrospective Study.评估国家消除疟疾规划的流行病学指标：回顾性研究。
Ethiop J Health Sci. 2023 Nov;33(6):1015-1026. doi: 10.4314/ejhs.v33i6.12.
8
For Malaria Elimination, India Needs to Integrate Its Research and Control Arms.为实现疟疾消除目标，印度需要整合其研究和防控部门。
Am J Trop Med Hyg. 2024 Jun 18;111(2):226-229. doi: 10.4269/ajtmh.24-0011. Print 2024 Aug 7.
9
Elimination of viral hepatitis: Evolution and India's response.消除病毒性肝炎：进展与印度的应对措施
Indian J Public Health. 2019 Oct-Dec;63(4):275-276. doi: 10.4103/ijph.IJPH_581_19.
10
Malaria vaccine technology roadmap.疟疾疫苗技术路线图。
Lancet. 2013 Nov 23;382(9906):1700-1. doi: 10.1016/S0140-6736(13)62238-2. Epub 2013 Nov 14.

本文引用的文献

1
Age-specific malaria vulnerability and transmission reservoir among children.儿童中特定年龄的疟疾易感性和传播源
Glob Pediatr. 2023 Dec;6:None. doi: 10.1016/j.gpeds.2023.100085.
2
Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond.红细胞前期疟疾疫苗：RTS,S、R21及其他。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):49-52. doi: 10.1080/14760584.2023.2292204. Epub 2023 Dec 14.
3
Emulsion and liposome-based adjuvanted R21 vaccine formulations mediate protection against malaria through distinct immune mechanisms.
乳剂和脂质体佐剂的 R21 疫苗制剂通过不同的免疫机制介导对疟疾的保护。
Cell Rep Med. 2023 Nov 21;4(11):101245. doi: 10.1016/j.xcrm.2023.101245. Epub 2023 Oct 31.
4
Issues related to the approval of the R21/Matrix-M malaria vaccine for use in Nigeria and Ghana.与R21/基质-M疟疾疫苗在尼日利亚和加纳获批使用相关的问题。
Front Public Health. 2023 Oct 4;11:1237011. doi: 10.3389/fpubh.2023.1237011. eCollection 2023.
5
Prevalence of malaria: A 7-year trend analysis from a tertiary care center, Puducherry.疟疾患病率：来自本地治里三级医疗中心的7年趋势分析
Trop Parasitol. 2023 Jan-Jun;13(1):28-33. doi: 10.4103/tp.tp_41_22. Epub 2023 May 19.
6
Should India be considering deployment of the first malaria vaccine RTS,S/AS01?印度是否应该考虑部署首款疟疾疫苗RTS,S/AS01？
BMJ Glob Health. 2022 Jan;7(1). doi: 10.1136/bmjgh-2021-007870.
7
Four decades of epidemiological data reveal trajectories towards malaria elimination in Kheda district (Gujarat), western part of India.四十年来的流行病学数据显示，印度西部古吉拉特邦赫达区（Kheda district）正在朝着消除疟疾的方向发展。
BMJ Glob Health. 2021 Dec;6(12). doi: 10.1136/bmjgh-2021-005815.
8
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.低剂量候选疟疾疫苗 R21 联合 Matrix-M 佐剂，季节性接种在布基纳法索儿童中的效果：一项随机对照试验。
Lancet. 2021 May 15;397(10287):1809-1818. doi: 10.1016/S0140-6736(21)00943-0. Epub 2021 May 5.
9
A micro-epidemiological report on the unstable transmission of malaria in Aligarh, India.印度阿里格尔疟疾不稳定传播的微观流行病学报告。
Parasite Epidemiol Control. 2020 Jun 27;11:e00161. doi: 10.1016/j.parepi.2020.e00161. eCollection 2020 Nov.
10
School-age Children as Asymptomatic Malaria Reservoir in Tribal Villages of Bastar Region, Chhattisgarh.学龄儿童是恰蒂斯加尔邦巴斯塔尔地区部落村庄无症状疟疾储存库。
Indian Pediatr. 2019 Oct 15;56(10):873-875.